Answer
Following oral administration in healthy volunteers, the elimination half-lives are approximately 40–60 hours for sunitinib and 80–110 hours for its primary active desethyl metabolite.
Sources for this answer
- Sunitinib 12.5mg Hard CapsulesTeva UK Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 3Document updated
Sources checked